| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |